OneLAX SENNA
- Product NDC
- 71399-0027
- 11-digit product format
- 713990027
- Labeler code
- 71399
- Product ID
- 71399-0027_4227fa19-b935-0fbc-e063-6294a90ac342
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- SENNA
- Dosage form
- SYRUP
- Route
- ORAL
- Labeler
- Akron Pharma Inc.
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2024-02-06
- Substance
- SENNOSIDES A AND B
- Active strength
- 417.12 mg/237mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- OneLAX SENNA
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SENNOSIDES A AND B | 417.12 mg/237mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 1B5FPI42EN |
| Rxcui | 702311 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71399-0027-8 | OneLAX SENNA | 237 mL in 1 BOTTLE | SYRUP | 237 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71399-0027 | ONELAX SENNA (SENNA) SYRUP [AKRON PHARMA INC.] | 1 | Current NDC, 1 package rows | 20240213_27fa8f54-ed84-4afd-8da3-8754da48643b.zip |
DailyMed RxNorm Mappings#
RxCUI, RxNorm string, TTY table| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|
| 702311 | sennosides 8.8 MG in 5 mL Oral Solution | PSN | d2a5a13a-e7e4-488a-b60b-4dd467efa971 | 4 |
| 702311 | sennosides, USP 1.76 MG/ML Oral Solution | SCD | d2a5a13a-e7e4-488a-b60b-4dd467efa971 | 4 |
| 702311 | sennosides 8.8 MG per 5 mL Oral Syrup | SY | d2a5a13a-e7e4-488a-b60b-4dd467efa971 | 4 |
| 702311 | sennosides, USP 26.4 MG per 15 ML Oral Solution | SY | d2a5a13a-e7e4-488a-b60b-4dd467efa971 | 4 |
| 702311 | sennosides, USP 8.8 MG per 5 ML Oral Solution | SY | d2a5a13a-e7e4-488a-b60b-4dd467efa971 | 4 |
| 702311 | sennosides 8.8 MG in 5 mL Oral Solution | PSN | 27fa8f54-ed84-4afd-8da3-8754da48643b | 2 |
| 702311 | sennosides 8.8 MG in 5 mL Oral Solution | PSN | e637777e-a39d-4e2f-a95c-4f524aa122f7 | 2 |
| 702311 | sennosides, USP 1.76 MG/ML Oral Solution | SCD | e637777e-a39d-4e2f-a95c-4f524aa122f7 | 2 |
| 702311 | sennosides, USP 1.76 MG/ML Oral Solution | SCD | 27fa8f54-ed84-4afd-8da3-8754da48643b | 2 |
| 702311 | sennosides 8.8 MG per 5 mL Oral Syrup | SY | 27fa8f54-ed84-4afd-8da3-8754da48643b | 2 |
| 702311 | sennosides 8.8 MG per 5 mL Oral Syrup | SY | e637777e-a39d-4e2f-a95c-4f524aa122f7 | 2 |
| 702311 | sennosides, USP 26.4 MG per 15 ML Oral Solution | SY | e637777e-a39d-4e2f-a95c-4f524aa122f7 | 2 |
| 702311 | sennosides, USP 26.4 MG per 15 ML Oral Solution | SY | 27fa8f54-ed84-4afd-8da3-8754da48643b | 2 |
| 702311 | sennosides, USP 8.8 MG per 5 ML Oral Solution | SY | e637777e-a39d-4e2f-a95c-4f524aa122f7 | 2 |
| 702311 | sennosides, USP 8.8 MG per 5 ML Oral Solution | SY | 27fa8f54-ed84-4afd-8da3-8754da48643b | 2 |
| 702311 | sennosides 8.8 MG in 5 mL Oral Solution | PSN | 40202c76-4273-88fd-e063-6394a90a07b2 | 1 |
| 702311 | sennosides, USP 1.76 MG/ML Oral Solution | SCD | 40202c76-4273-88fd-e063-6394a90a07b2 | 1 |
| 702311 | sennosides 8.8 MG per 5 mL Oral Syrup | SY | 40202c76-4273-88fd-e063-6394a90a07b2 | 1 |
| 702311 | sennosides, USP 26.4 MG per 15 ML Oral Solution | SY | 40202c76-4273-88fd-e063-6394a90a07b2 | 1 |
| 702311 | sennosides, USP 8.8 MG per 5 ML Oral Solution | SY | 40202c76-4273-88fd-e063-6394a90a07b2 | 1 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71399-0027-8 | 71399002708 | 237 mL in 1 BOTTLE (71399-0027-8) | 237 ml | 2024-02-06 | No | No | Historical |